Annual accounts receivable:
$142.00M+$47.18M(+49.76%)Summary
- As of today (May 30, 2025), AXSM annual accounts receivable is $142.00 million, with the most recent change of +$47.18 million (+49.76%) on December 31, 2024.
- During the last 3 years, AXSM annual accounts receivable has risen by +$142.00 million (+100.00%).
- AXSM annual accounts receivable is now at all-time high.
Performance
AXSM Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$161.40M+$19.40M(+13.66%)Summary
- As of today (May 30, 2025), AXSM quarterly accounts receivable is $161.40 million, with the most recent change of +$19.40 million (+13.66%) on March 31, 2025.
- Over the past year, AXSM quarterly accounts receivable has increased by +$59.96 million (+59.12%).
- AXSM quarterly accounts receivable is now at all-time high.
Performance
AXSM Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AXSM Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +49.8% | +59.1% |
| 3 y3 years | +100.0% | - |
| 5 y5 years | - | - |
AXSM Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | at high | +898.3% |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
AXSM Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $161.40M(+13.7%) |
| Dec 2024 | $142.00M(+49.8%) | $142.00M(+14.4%) |
| Sep 2024 | - | $124.10M(+3.1%) |
| Jun 2024 | - | $120.34M(+18.6%) |
| Mar 2024 | - | $101.43M(+7.0%) |
| Dec 2023 | $94.82M | $94.82M(+20.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $78.42M(+16.3%) |
| Jun 2023 | - | $67.41M(+50.5%) |
| Mar 2023 | - | $44.79M(+18.8%) |
| Dec 2022 | $37.70M(>+9900.0%) | $37.70M(+85.7%) |
| Sep 2022 | - | $20.30M(+25.6%) |
| Jun 2022 | - | $16.17M(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00 |
FAQ
- What is Axsome Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Axsome Therapeutics?
- What is Axsome Therapeutics annual accounts receivable year-on-year change?
- What is Axsome Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly accounts receivable year-on-year change?
What is Axsome Therapeutics annual accounts receivable?
The current annual accounts receivable of AXSM is $142.00M
What is the all time high annual accounts receivable for Axsome Therapeutics?
Axsome Therapeutics all-time high annual accounts receivable is $142.00M
What is Axsome Therapeutics annual accounts receivable year-on-year change?
Over the past year, AXSM annual accounts receivable has changed by +$47.18M (+49.76%)
What is Axsome Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of AXSM is $161.40M
What is the all time high quarterly accounts receivable for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly accounts receivable is $161.40M
What is Axsome Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, AXSM quarterly accounts receivable has changed by +$59.96M (+59.12%)